Istituto Ortopedico Rizzoli

Bologna 40136

1 studies enrolling now · 12 studies all time

What they study most

Advanced Solid Tumor, Advanced Solid Tumors, Arthroplasty, Replacement, Knee, Differentiated Thyroid Cancer (DTC), Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Leiomyosarcoma, Metastatic Soft Tissue Sarcoma, Osteogenesis Imperfecta, Osteosarcoma, Pigmented Villonodular Synovitis, Relapsed Ewing Sarcoma

Studies at this site

• Primary Tumor Research and Outcomes Network — Recruiting now
• Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo) — Running, not enrolling
• A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations — Completed
• Study of Vimseltinib for Tenosynovial Giant Cell Tumor — Running, not enrolling
• Setrusumab vs Placebo for Osteogenesis Imperfecta — Running, not enrolling
• A Study of INCB059872 in Relapsed or Refractory Ewing Sarcoma — Stopped early
• A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery — Completed
• Tenosynovial Giant Cell Tumors (TGCT) Observational Platform Project — Completed
• Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma — Completed
• Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors — Completed
• A Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement Surgery — Completed
• Sarcoma Study of MORAb-004 Utilization: Research and Clinical Evaluation — Completed